Andere talen Thyrocare Technologies Limited NSE India S.E.

Aandelen

THYROCARE

INE594H01019

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:50 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
626,1 ^INR	+0,58%		-0,78%	-2,71%

10/05	Dr. LalPath Labs in India boekt meer winst in het vierde kwartaal dankzij een gezonde vraag naar tests	RE
16/04	Thyrocare Technologies Limited kondigt ontslag aan van Ankit Brijpuriya als Deputy Company Secretary en Deputy Compliance Officer	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	10/05
Thyrocare Technologies Limited Announces Resignation of Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	16/04
Thyrocare Technologies Completes Acquisition of Think Health; Shares Jump 6%	28/02
Thyrocare Technologies Limited completed the acquisition of Think Health Diagnostic Private Limited.	27/02
Thyrocare Technologies Limited Pays and Settles Due Cess Amount Including Interest and Penalty Amount to Navi Mumbai Municipal Corporation, Cess Department	23/02
Thyrocare Technologies Appoints Chief Commercial Officer	23/02
Thyrocare Technologies Limited Appoints Nitin Chugh as Chief Commercial Officer	23/02
Thyrocare Technologies Posts Gains in Fiscal Q3 Consolidated Profit	02/02
Thyrocare Technologies Limited Appoints Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	01/02
Thyrocare Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01/02
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01/02
Thyrocare Technologies to Acquire 100% Stake in Think Health Diagnostic	01/02
Thyrocare Technologies Limited agreed to acquire Think Health Diagnostic Private Limited for INR 3.2 million.	01/02
Indian shares set to open lower with HDFC, Fed decision in focus	20-09-23
Thyrocare Technologies Forms Joint Venture in Tanzania	20-09-23
Thyrocare Technologies Limited Enter into A Subscription Agreement At Tanzania with Kastipharm Limited and Other Individuals for Setting Up A Joint Venture Company	19-09-23
Thyrocare Technologies Names CFO	02-08-23
Thyrocare Technologies Limited Appoints Alok Kumar Jagnani as Chief Financial Officer	01-08-23
Thyrocare Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01-08-23
Thyrocare Technologies CFO Resigns	17-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Thyrocare Technologies Limited NSE India S.E.

Aandelen

THYROCARE

INE594H01019

Andere talen

Filters